Mistrík Martin Ph.D.

Journals

MINARIK, J., T. PIKA, J. RADOCHA, A. JUNGOVA, J. STRAUB, T. JELINEK, L. POUR, P. PAVLICEK, M. MISTRÍK, L. BROZOVA, P. KRHOVSKA, K. MACHALKOVA, P. JINDRA, I. SPICKA, H. PLONKOVA, M. STORK, J. BACOVSKY, L. CAPKOVA, M. SYKORA, P. KESSLER, L. STEJSKAL, A. HEINDORFER, J. ULLRYCHOVA, T. SKACEL, V. MAISNAR, R. HAJEK
Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice. BMC Cancer. 2021, 21(1), 73, ISSN: 1471-2407, PMID: 33451293,
MAJERA, D., M. MISTRÍK
Effect of Sepatronium Bromide (YM-155) on DNA Double-Strand Breaks Repair in Cancer Cells. International Journal of Molecular Sciences. 2020, 21(24), 9431, ISSN: 1422-0067, PMID: 33322336,  PDF.
CHYRA, Z., T. SEVCIKOVA, P. VOJTA, J. PUTEROVA, L. BROZOVA, K. GROWKOVA, J. FILIPOVA, M. ZATOPKOVA, S. GROSICKI, A. BARCHNICKA, W. JEDRZEJCAK, A. WASCUK-GAJDA, A. JUNGOVA, A. MIKULASOVA, M. HAJDÚCH, M. MOKREJS, L. POUR, M. STORK, L. HARVANOVA, M. MISTRÍK, G. MIKALA, P. ROBAK, A. CZYZ, J. DEBSKI, L. USNARSKA-ZUBKIEWICZ, A. JURCZYSZYN, L. STEJSKAL, G. MORGAN, F. KRYUKOV, E. BUDINSKA, M. SIMICEK, T. JELINEK, M. HRDINKA, R. HAJEK
Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis. Haematologica. 2020, 106(2), 601-604, ISSN: 0390-6078, PMID: 32381580,

Open positions

Project: DNA damage signaling in the cellular response to stress
Supervisors: Mistrík Martin Ph.D.
Available: 1
Intended for: Doctoral training
Summary: 1 place in full-time study
Project: Cellular stress in health and disease
Supervisors: Mistrík Martin Ph.D., Moudrý Pavel Ph.D., Škrott Zdeněk Ph.D.
Available: 3
Intended for: Doctoral training